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List of acylcarnitine esters 
Name Acyl-chain [M+H]+ CAS number 
L-carnitine C0 162 541-15-1 
Acetylcarnitine C2 204 204259-54-1 
Propionylcarnitine C3 218 20064-19-1 
Butyrylcarnitine C4 232 25576-40-3 
Isobutyrylcarnitine C4 232 25518-49-4 
2-methyl-butyrylcarnitine C5 246 256928-75-3 
Isovalerylcarnitine C5 246 31023-24-2 
Glutarylcarnitine C5DC 276 102636-82-8 
Hexanoylcarnitine C6 260 22671-29-0 
Octanoylcarnitine C8 288 25243-95-2 
Decanoylcarnitine C10 316 3992-45-8 
Lauroylcarnitine C12 344 25518-54-1 
Myristoylcarnitine C14 372 25597-07-3 
Palmitoylcarnitine C16 400 2364-67-2 
Stearoylcarnitine C18 428 25597-09-5 







Carnitine is a low-molecular-weight compound that has an obligate role in the mitochondrial 
oxidation of long-chain fatty acids (acyl groups) and energy production. Therefore, 
acylcarnitines are essential diagnostic markers for complex diseases, fatty acid metabolism 
disorders, and disorders related to amino acids metabolism. Biochemical screening of the 
acylcarnitine profile is performed in clinical laboratories using tandem mass spectrometry as 
the analytical platform.   
Analysis of acylcarnitine species can become challenging because several species occur in an 
isomeric form. A selective and sensitive UHPLC-MS/MS method has been established to 
analyze an acylcarnitine profile of acylcarnitines with acyl-chain lengths C4-C18. The method 
includes four isomeric species, two C4 isomers (butyrylcarnitine and isobutyrylcarnitine) and 
two C5 isomers (2-methylbutyrylcarnitine and isovalerylcarnitine). The analysis was 
conducted on a Waters Acquity ultra performance liquid chromatograph (UPLC) coupled 
with a triple quadrupole mass spectrometer operated in electrospray positive mode. 
Optimization of separation involved testing various parameters such as mobile phase 
composition, additives, and effect of ion-pairing reagents. The separation efficiency of the 
C18 column was compared to amide column to investigate the optimal settings for separation 
of short-chain polar acylcarnitines. The chromatographic separation was achieved using 
ACQUITY UPLC HSS C18 (1.8 µm, 2.1 x 100 mm) column. Gradient elution was 
accomplished with a mobile phase consisting of 0.1% formic acid in water and 0.1% formic 
acid in acetonitrile. High specificity was obtained with MRM operation mode of MS 
instrumentation. The process of development MRM method involved a series of testing 
various parameters such as cone voltage, collision energy and flow rate of the collision gas to 
achieve the optimal set of conditions. Fragmentation of all acylcarnitines provides a 
characteristic fragment ion of m/z 85. The limit of detection of the acylcarnitine esters 
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1.1 The biological role of carnitine 
 
Carnitine (β-hydroxy-γ-N-trimethylammonium butyrate) is a low-molecular-weight 
hydrophilic quarternary amine, involved in the lipid metabolism and energy production [1, 2]. 
The molecule of carnitine is employed as a carrier of activated fatty acids across the inner 
mitochondrial membrane, where the fatty acids undergo β-oxidation [2]. Basically, it delivers 
substrate for oxidation which leads to energy production. Carnitine participates in a reversible 
esterification reaction in which acylcarnitines are generated. Various fatty acyl groups are 
transferred from coenzyme A to the beta hydroxyl group of L-carnitine which forms 
acylcarnitines with acyl-chains of different lengths [3]. 
 
Figur 1 Molecule of L-carnitine (β-hydroxy-γ-N-trimethylammonium butyrate) 2D (left) and 3D (right). Esterification 
of L-carnitine on the beta hydroxyl group generates various acyl carnitine esters [3].  
 
Biologically active stereoisomer L-carnitine is present nearly in all the body cells. In a human 
organism, 75% of carnitine content comes from the food; therefore, its bioavailability varies 
and depends on the composition of the diet. Animal products, especially red meat, is the most 
significant food source of carnitine. The bioavailability of carnitine is higher for vegetarians 
and vegans than for meat eaters since they are adapted to low-carnitine diet [4]. The carnitine 
content that is not obtained through the diet is synthesized in the liver and kidneys from lysine 
and methionine, which are two essential amino acids [5]. Free-L-carnitine is transported with 
bloodstream and extracellular fluids to various tissues. Intracellular transport depends on its 




and passive transport across membranes of enterocytes [4]. Carnitine binds activated acyl 
chains inside the body cells during a metabolic activity where various acylcarnitines are 
generated. A function of long-chain acyl carnitine esters is a transport of fatty acyl moieties 
via the mitochondrial membrane into the matrix (see figure 2) where they undergo fatty acid 
oxidation (FAO). Short-chain and medium-chain acylcarnitines are involved in the removal of 
organic acids [6]. FAO is a necessary process that generates energy in tissues where the 
carnitine molecule plays a vital role as a carrier [7].  
 
Figure 2 Transfer of free fatty acids from cytosol to mitochondrial matrix [8] 
 
FAO disorders and organic acid metabolism disorders are investigated by screening acyl 
carnitine profile alterations [2, 7]. The metabolic evaluation includes the analysis of 
acylcarnitines in various matrices, including plasma, blood, urine or tissues. Obvious 
deficiencies arise either from a genetic mutation of carnitine transporters, inborn errors of 
metabolism, or they are associated with other disorders [9]. A particular concentration of 
carnitine in plasma and tissues is essential for the normal function of metabolism [10]. 
Extremely low levels of carnitine can result in cardiomyopathy, congestive heart failure, 
encephalopathy, hepatomegaly, and neuromuscular disorders [3]. Carnitine deficiency has 
been associated with cirrhosis and liver disorders, obesity, endocrine disorders, diabetes and, 
inflammatory bowel diseases (IBD) [4, 7]. 
IBD is a chronical intestinal disorder that includes two principle types: Crohn’s disease and 




by an interaction of genetic and non-genetic factors. However, the pathogenesis of IBD 
remains unknown [7, 11]. IBDs such as Crohn’s disease and ulcerative colitis are 
characterized by malabsorption of some nutrients. One of them is carnitine, which is a crucial 
molecule involved in the energy metabolism of the epithelial cells [12]. L-carnitine has an 
impact on several factors involved in the outcome of IBD including oxidative stress, the level 
of activation of the immune cells, and the integrity of the epithelial barrier [13]. Thus, acyl 
carnitine profile in patients with IBD is investigated, since deficiency of some isoforms of 
carnitine may play a role in the etiology and pathogenesis of the disease [7]. The development 
of a selective and sensitive bioanalytical method for analysis of acyl carnitine profile includes 





Development in analytical technology plays an influential role in the development of new 
methods. The technology available for bioanalytical purposes significantly improved over the 
last decades. Progress was achieved with HPLC-UV based techniques and fluorescent 
detection for LC in the late 1980s [14, 15]. However, the disadvantages of the mentioned 
technique include a lack of selectivity and a lack of structural information [15]. A revolution 
in bioanalysis occurred with the possibility to connect the separation ability of UHPLC with 
high sensitivity detection of MS instrumentation. The possibility to couple a chromatography 
separation module coupled with the mass spectrometer was achieved using atmospheric 
pressure ionization (API) [16]. A great selectivity, qualitative and quantitative information 
and high sensitivity were achieved after an invention of this hyphenated technique which 
combines liquid chromatography with tandem mass spectrometry (MS/MS) [14]. The 
development of ultra-high-performance liquid chromatography (UHPLC) allows better 
separation of complex mixtures in shorter time. Thus – the combination UHPLC-MS/MS 









UHPLC-MS/MS is a hyphenated technique that combines a separation ability of UHPLC with 
a highly sensitive MS/MS detection (figure 4) [17]. This technique is commonly used for 
bioanalysis due to its selectivity and sensitivity [18], and it was applied for the analysis of the 





Figure 4 Schema of LC-MS/MS technique [19]. A complex sample is introduced into the LC column where the 
mixture is separated. Separated sample is consequently ionized in an ion source at the atmospheric pressure 
(here ESI). Ions are selected by mass filters (here QqQ) and sent to the detector of MS instrumentation.  
 
1.3.1 UHPLC principles 
 
Ultra-high-performance liquid chromatography is a separation technique that pumps a mixture 
of analytes in the mobile phase under high pressure, through a stationary phase in the 
chromatographic column [20]. The UHPLC, compared with the classical LC technique, is 
characterized by small-diameter steel columns packed with small totally porous particles that 
act as a support for the stationary phase. The mixture of analytes is separated by their 
different retention times, which depend on the physicochemical properties of the analyte, the 
stationary phase and the mobile phase [15]. With a given analyte, stationary phase and mobile 
phase retention time can also be influenced to various degrees as function of column 
temperature. Chromatographic separation can be enhanced by lowering a band broadening in 
order to achieve more narrow chromatographic peaks. Band broadening factors such as 
longitudinal and Eddy diffusion can be reduced. Longitudinal diffusion is a dispersion of 
analyte molecules in the solvent due to the concentration gradient at the band edges. Its effect 
can be reduced by using a high linear velocity. Eddy diffusion describes the fact that every 
analyte molecule can travel on the different trajectories due to nonhomogeneous column 
packing [21]. As a function of the particle size, it can be reduced by using smaller stationary 
phase particles. The optimal flow rate depends on the diameter (dp) of the particles used to 




higher than for columns packed with larger particles (see figure 4). Using narrow columns 
filled with small particles at the optimal flow rate increases the back pressure. Modern 
UHPLC instrumentation has the potential to deliver narrow chromatography peaks with the 
ability to operate at back pressures up to 18 000 psi [15, 23]. 
A suitable column for the chromatographic separation is determined by the physical 
properties of the target analytes. Characteristics that are considered for the selection are 
hydrophobicity, charge, and size of the molecules. The nature of the stationary phase 
determines the elution profile [24]. The internal diameter of UHPLC columns is in the range 
of millimeters. Generally, a smaller internal diameter provides better separation [24]. 
 
1.3.2 UHPLC column packing 
 
Most UHPLC columns are made by using spherical, totally porous silica as support for the 
various stationary phases. The most popular columns are the C-18 (also named RP-18) 
columns. Here, 18 carbon long alkyl chains are covalently bounded to the surface of the silica 
particles. The diameter of spherical silica beads in UHPLC is between 1.8 µm and 2.5 µm 
[24]. Column efficiency increases with decreasing diameter of the beads (figure 5). Bead size 
is limited due to increasing pressure and reduced flow rate in the column [23]. Packing 
material with the irregular shape of the particles was used in the first columns to increase the 






 Figure 5 Van Deemter plot. The window for the optimal linear flow rate is wider when using small particles as the 
column filling [22] 
 
1.3.3 UHPLC column types 
 
UHPLC columns are available in many different lengths, inner diameters, and various 
stationary phases. Commonly used column types classified by separation mechanism include 
ion exchange, reverse-phase and normal-phase UHPLC columns [14]. Ion exchange columns 
contain cationic or anionic stationary phase. Polar analytes carried by a buffer are separated 
based on their charge. Reversed-phase column is the most commonly used one for a wide 
range of different types of analytes. Non-polar molecules interact with the hydrophobic 
stationary phase and retain in the column longer than polar compounds. Non-polar carbon 
chains are bonded to silica beads which gives the stationary phase hydrophobic properties 
[25]. Acetonitrile or methanol mixed with water are almost exclusively used as mobile phase 
components of reversed-phase chromatography.  In the analysis of the acyl carnitine profile, 
reverse-phase C18 column is commonly used. The gradient elution regulates the retention of 
hydrophilic short-chain acyl carnitine esters. A weak starting mobile phase is linearly 
increased in order to make the long-chain acylcarnitines elute later. Both isocratic and 
gradient elution can be used with reverse-phase columns. Normal-phase chromatography is 
the opposite: the stationary phase is a hydrophilic silica, and the polar molecules retain in the 




1.3.4 Mass spectrometry instrumentation 
 
The invention of the hyphenated technique of chromatographic separation with MS detection 
has been revolutionary in bioanalysis due to its high sensitivity and selectivity [16, 17]. 
Various mass analyzers are used for ion selection, including quadrupole mass filter, time-of-
flight (TOF) or ion traps [20].  Multiple reaction monitoring is a commonly used mass 
spectrometry technique which can quantify compounds within various complex mixtures. 
This technique applies a triple quadrupole that first identifies ions of interest. Subsequent 
fragmentation produces daughter ions that can be selected for quantification. Only ions that 
meet both criteria, specific mother ion of interest and the daughter ion of interest, are isolated. 
The high sensitivity of this technique is achieved by ignoring the flow of all the other ions and 
hence increase the signal to noise (S/N) ratio [14]. The MRM technique is used for the 
quantitative analysis of endogenous and exogenous compounds in plants, environmental 
samples, blood, serum, plasma, urine, saliva, tissues and other materials. 
 Mass spectrometry instrumentation includes an ionization source where the molecule of 
interest is ionized and in most cases also fragmented. Ions are separated according to their 
mass-to-charge (m/z) ratio by various mass filters. One of the most popular mass filters are 
the so-called quadrupole instruments. In this work we have used a triple quadrupole 
instrument. The separation is based on the same deflection of ions with the same m/z ratio 
[16]. Basically, masses of all the ion and fragments are measured. The mass spectrum 
displays a plot of the ion signal to the m/z ratio. Known masses and characteristic 
fragmentation patterns are tools for identification of molecules in the sample [26]. 
1.3.4.1 Ion sources 
 
Two major types of ionization that are used in LC-MS systems in bioanalytical laboratories 
are electrospray ionization (ESI) and atmospheric pressure chemical ionization (APCI) [20]. 
When choosing between APCI and ESI, characteristics such as analyte volatility, analyte 





Figur 6 Applicability of APCI and ESI as a function of a polarity of an analyte and its molecular weight [16].  
 
 ESI is a soft ionization source convenient for ionization of thermolabile molecules, where 
little energy is used in order to achieve a gentle fragmentation. Samples are pumped through a 
capillary with a specific voltage and nebulized to charged droplets. Rapid evaporation of the 
charged droplets causes a transfer of the residual electric charge to the analyte (figure 7) [27]. 
Ions are subsequently transferred to a high vacuum in the mass spectrometer. The ionization 
source can operate in both positive and negative mode, which allows the selection of positive 
or negative ions [16]. ESI is widely used when analyzing biological molecules [26]. ESI 






Figur 7 Schema of ESI ionization source [27]. The Taylor cone emits nebulized liquid drops under high voltage. 
Solvent evaporation results in charged droplets. Droplet dissociation produce a stream of ions when the charge of 
the droplet exceeds Rayleigh limit. 
  
When using APCI, a liquid sample is pumped through a capillary and nebulized. Corona 
discharge causes the ionization of solvent molecules, which transfer their charge to the 
analyte. APCI is applied for example in lipid analysis [26]. 
1.3.4.2 Mass analyzers 
 
The selection of ions according to their m/z ratio takes place in an electric and magnetic field, 
in a vacuum of a mass analyzer. There are several different ways of selecting ions as 
mentioned previously. A quadrupole mass filter was used during this laboratory work. A 
quadrupole mass analyzer consists of four parallel conducting rods. Changing voltage on the 
pairs of opposite rods creates an oscillating electric field in which ions are selected based on 
their flight trajectories (see figure 8). Mass spectrometer with a single quadrupole can analyze 
only ions created in the ion source [20]. Single quadrupole can operate in two modes, full 
scan and selected ion monitoring (SIM). The dominant type of mass analyzer likely to be used 
in LC-MS systems for quantitative bioanalysis is a triple quadrupole (QqQ). Two mass 
analyzers are used for tandem mass spectrometry (MS/MS). The triple quadrupole mass 
analyzer provides better specificity and structural information than a single quadrupole since 
it involves an extra selectivity step. At the first selectivity step, a precursor ion is selected in 
the first quadrupole and fragmented in the collision cell (second quadrupole) by collision-
induced dissociation. Collisions with an inert gas at a specific collision energy result in 




quadrupole selects fragment ions of interest before they reach a detector (see figure 9). Co-
eluting compounds might provide ions of the same m/z. However, the probability of two 
compounds having the same retention times, the same precursor ion and the same fragment 
ion is very low. 
 
Figure 8 Schema of a quadrupole mass analyzer [28]. Changing voltage on the pairs of opposite rods creates an 
oscillating electric field in which ions are selected based on their flight trajectories. 
 
A triple quadrupole can operate in several modes [26]:  
Table 1 Operation modes of the triple quadrupole mass analyzer 
Mode Q1 Q3 Applications 
Parent (precursor) ion 
scan 
Scanned Fixed Detection of analytes with a common 
daughter ion (m/z = 85 for acylcarnitines) 
Daughter (product) ion 
scan 
Fixed Scanned Scan of fragment ions of one parent ion 
(determination of MRM transitions) 
Neutral loss scan Scanned  Scanned Detection of analytes that eliminate a 
common molecule (glucuronates) 
Multiple reaction 
monitoring (MRM) 
Fixed Fixed Highly-specific detection, used in this study 






Figure 9 Schema of MRM method. Selectivity step 1: “Q1” selects the molecular ion of interest. Selectivity step 2: 
“Q2” selects a product ion of the molecular ion of interest [29] 
 
1.4 Analytical challenges in bioanalysis 
 
UHPLC-MS/MS technique used in bioanalysis is the right choice for its selective and 
sensitive detection ability of analytes of interest in very complex matrices. A bioanalytical 
method should meet certain requirements and deliver quantitative results with high accuracy 
and precision. The acylcarnitine profile can be established by direct infusion to ESI-MS/MS. 
However, this method cannot separate isobaric species and is usually not used in quantitative 
analysis. Therefore, chromatographic separation coupled with modern sensitive and selective 
MS detection provide more clinically relevant results [9]. The workflow for the development 
of a successful bioanalytical UHPLC-MS/MS method requires three main steps: 1) sample 
preparation, 2) chromatographic parameters and 3) mass spectrometry [14]. All the three steps 
can influence each other; therefore the method development process is very complex and 




Several challenges must be considered when developing a bioanalytical method. A biological 
matrix can result in interferences or ion suppression in a mass spectrometry assay. The 
required level of sensitivity (low levels of detection and quantification) should be achieved to 
detect the trace amount of the compound of interest in the complex matrix. The time of the 
analysis must be balanced against all the requirements and considerations. Another important 
consideration is a resolution of a peak of interest from all other endogenous compounds. 
1.5 Metabolomics 
 
Metabolomics is an approach that is based on a comprehensive analysis of metabolites and 
low-molecular-weight molecules in a biological sample [30]. The field of metabolomics 
provides several challenges in comparison to other “omics.” The approach to analyze the 
whole metabolome must deal with a wide array of small molecules of various chemical 
functionalities that contribute to metabolism. Unlike other “omics” fields such as lipidomics 
or proteomics, metabolomics must focus on specific groups within each metabolome since 
metabolites have no standard chemical functionality. Relative quantification of metabolites 
can be achieved with isotope labelling coupled with MS. Stable isotopes have the same 
chemical formula and structure and behave identically during chromatographic separation. 
Isotope of a given element contains the same number of protons, but different number of 
neutrons. An MS can differentiate isotopes by their different m/z ratio. Isotopes exhibit nearly 
identical chemical behaviour; therefore, the stable isotopes are the best internal standards to 
enable quantification [31]. 
 
Current metabolomics technologies are powerful tools in clinical medicine. Analysis of 
metabolites provides information for the diagnosis of complex metabolic diseases including 
inborn errors of metabolism. Metabolomics stands behind the discovery of new therapeutic 
targets and biomarkers and thus has a significant potential to change a field of clinical 
chemistry [30].  
Methods in the field of metabolomics are continually improving with the development of new 
analytical techniques and instrumentation. A metabolomic analysis includes both, endogenous 
metabolites linked to enzymatic activities and metabolites derived from external sources like 
food and medication. Current technologies enable rapid discoveries, measurement of 




a tool to search for specific markers of diseases as well as metabolite profiles associated with 
the external environment and their associations with disease risk. Metabolomics studies 
include for example relationship between diet and disease, search for new cardiovascular 
biomarkers [33], metabolite profile analysis and risk of developing diabetes [5, 34] or 
metabolic indicators of cancer [35]. The most recent metabolomics research in the field of 
clinical medicine introduces an application of metabolomics in viral pneumonia [36], obesity 
studies [4], Parkinson’s disease [32], breast cancer tumours [37], or the role of acyl carnitine 





The principal objective of this project was to develop an analytical method for the 
determination of endogenous carnitine and acylcarnitines in colonic mucosa. A set of 
experimental conditions was investigated to create an analytical method for the determination 
of acylcarnitines. Several methods are developed for the analysis of acylcarnitines in different 
tissues by mean of liquid chromatography coupled with mass spectrometry (LC/MS) [6]. 
These methods require laborious and time-consuming preparation steps such as solid phase 
extraction and derivatization. Moreover, other methods are restricted to only a few acyl 
carnitine species and are not able to detect and quantify isomers [38].   
Metabolomics analysis on IBD patients’ colon biopsies revealed alteration in fatty acid 
metabolism. Furthermore, changes of acyl carnitine profile in IBD patients’ plasma were 
previously reported [7]. Therefore, comprehensive quantification of acyl carnitine species in 
colon mucosa is important to establish the link between fatty acid metabolism and IBD 
occurrence and progression. 
The main goal is therefore to develop a simple UHPLC–MS/MS method for the separation 
and quantification of acylcarnitines including the isomeric forms with a minimal sample pre-
treatment. The time-consuming sample pre-treatment processes involve synthesized reagents 
that can cause unwanted reactions and it can influence the determination of accuracy [38]. 
This project aims to develop a new UHPLC-MS/MS based analytical method for separation 
and quantification of acyl carnitines that avoids critical process parameters.  
Analytical methods using UHPLC-MS/MS include analysis in the following modes: full scan, 
selected ion monitoring (SIM), daughter ion scan, parent ion scan and multiple reaction 
monitoring (MRM) [26, 39]. Chromatographic separation is a physical separation of the 
acylcarnitines performed prior to the high-tech detection with a highly specific MS 
instrumentation. The optimization of the chromatographic conditions is a necessary step that 
includes varying the composition of solvents in the mobile phase, adjusting the pH and 
optimizing the gradient elution [18]. 
Full scan monitoring is performed to provide a qualitative picture of the composition of the 
sample [39]. It involves scanning the actual mass range, in this case, scanning from m/z = 50 




In the selected ion monitoring (SIM) mode, data are collected on the selected masses for 
quantitative studies on the specific ions of interest [39]. Cone voltage (CV) must be 
investigated to obtain the optimal value that provides the desired fragmentation. SIM is also 
one of the methods of choice to determine a limit of detection (LOD) and a lower limit of 
quantification (LLOQ) of individual acylcarnitines. In SIM, minimum 2 ions should be used, 
one ion as the quantifier ion and one ion as a qualifier ion. 
Daughter ion scan mode selects a parent ion, and the scan gives all the daughter ions resulting 
from fragmentation of that ion [39]. Cone voltage (CV) must be adjusted for this method to 
provide a high intensity of the molecular ion. Lower fragmentation is usually achieved by 
lowering down the CV value. Two more parameters must be determined: collision energy 
(CE) and flow rate of the collision gas, to obtain good fragmentation of the molecular ion, in 
order to get information about the masses of daughter ions. 
Multiple reaction monitoring (MRM), also known as selective reaction monitoring (SRM) is a 
highly specific and sensitive mass spectrometry technique that can selectively quantify 
compounds within complex mixtures [39]. Our goal is to obtain all the necessary parameters 
and data to develop the MRM technique for analysis and quantification of acyl carnitine 
molecules in the colonic tissue and to find LOD and LLOQ with this technique. 
The appropriate validation of the analytical method is essential to demonstrate that the new 
method is suitable for the analysis of acylcarnitines in colon biopsies. Validation of a method 
involves using experimental design to prove that the method can produce accurate and precise 
quantitative results. 
A successful analytical method can be a tool for investigating the changes in the mucosal 




3 Material and methods 
3.1 Chemicals and reference standards 
 
Chemicals and carnitines reference standards used during the laboratory work are summarized 
in the table 2 and table 3. 
Table 2 Chemicals  
Chemical Abbreviation CAS Producer 
Acetonitrile (UPLC/UHPLC grade) ACN 75-05-8 VWR Chemicals 
Ammonium acetate NH4AcO 631-61-8 Sigma Aldrich 
Heptafluorobutyric acid HFBA 375-22-4 Sigma Aldrich 
Hexanesulfonic acid natrium salt HSA 2832-45-3 Sigma Aldrich 
Methanol (UPLC/UHPLC grade) MeOH 67-56-1 VWR Chemicals 
 
Table 3 Acylcarnitine reference standards 
Acylcarnitine reference standard (1mg/ml) Acyl chain CAS number Producer 
L-carnitine C0 541-15-1 Sigma Aldrich 
Acetylcarnitine C2 204259-54-1 
Propionylcarnitine C3 20064-19-1 
Butyrylcarnitine C4 25576-40-3 
Isobutyrylcarnitine C4 25518-49-4 
2-methyl-butyrylcarnitine C5 256928-75-3 
Isovalerylcarnitine C5 31023-24-2 




Hexanoylcarnitine C6 22671-29-0 
Octanoylcarnitine C8 25243-95-2 
Decanoylcarnitine C10 3992-45-8 
Lauroylcarnitine C12 25518-54-1 
Myristoylcarnitine C14 25597-07-3 
Palmitoylcarnitine C16 2364-67-2 
Stearoylcarnitine C18 25597-09-5 
Oleoylcarnitine C18:1 13962-05-5 
Oleoyl-1-
13
C-L-carnitine hydrochloride   Sigma Aldrich 
 
 
3.2 LC-MS/MS conditions 
 
The analysis was conducted on a Waters Acquity Ultra Performance Liquid Chromatograph 
(UPLC) coupled with triple quadrupole mass spectrometer operated in electrospray positive 
mode. The chromatographic separation was established using ACQUITY UPLC HSS C18 
(1.8 µm, 2.1 x 100 mm) column. The mobile phase consisted of 0.1% formic acid in water 
(mobile phase A) and 0.1% formic acid in acetonitrile (mobile phase B).  
Table 4 Experimental parameters 
Experimental parameters Conditions 
LC system Waters ACQUITY UPLC system 
UPLC columns ACQUITY UPLC HSS C18 (1.8 µm, 2.1 x 100 mm) 
X Bridge BEH Amide (2.5 µm, 2.1 x 75 mm) 
Mobile phases A1: 0.1% formic acid in water 




(0.1% formic acid in methanol) 
A2: 10 mM ammonium acetate in water 
B2: 10 mM ammonium acetate in acetonitrile 
(10 mM ammonium acetate in methanol) 
Flow rate 0.3 ml/min 
Injection volume 300 µl 
Column temperature 50°C 
Sample temperature Room temperature 
Sample diluents MeOH:H2O 1:1 
H2O 
MS system Waters Tandem Quadrupole Mass Spectrometer 
Ionization mode ESI+ 
Capillary voltage 3.0 kV 
Source temperature 200°C 
Collision gas Argon 
Collision gas flow rate 0.25 ml/min 
Dwell time 0.600 s 







3.3 Sample preparation 
 
Several methods have been developed to determine acylcarnitines in body liquids and tissues. 
Most of the methods use tandem mass spectrometry (MS/MS) as a detection tool. These 
methods are successful, but they do not separate isomers [38]. A method using liquid 
chromatography coupled with tandem mass spectrometry (LC-MS/MS) has been developed in 
order to separate isomers. However, samples require laborious processing before the analysis 
which includes time-consuming derivatization. Derivatization is required because the short-
chain acylcarnitines do not retain on a reverse phase column due to their hydrophilic 
properties. Acylcarnitines are often derivatized to their butyl-esters. Alternative derivatization 
methods include synthesized reagents [2, 38]. Derivatization process can cause unwanted 
reactions that can influence the determination of the accuracy of the quantifications [2]. Thus, 
a UHPLC-MS/MS method has been established to separate and identify underivatized 
compounds [38]. In this project, we have focused on the UHPLC separation of underivatized 
acylcarnitines with subsequent MS/MS identification.  
Acylcarnitine reference standards of concentration 1 mg/ml were purchased from Sigma 
Aldrich. The reference standards were further diluted using methanol:water (1:1) as a dilution 
solvent. Dilutions used for each step of the method development are mentioned in each 
descriptive section of the chapter 3. Diluted reference standards were used in this project for 
the method development.  
3.4 Analytical methods 
3.4.1 UHPLC method development 
 
A UHPLC method was developed in order to achieve chromatographic separation. Despite 
the ability of the MS/MS detector to analyze a mixture of acylcarnitines in the positive ion 
mode using the multiple reaction monitoring (MRM), chromatographic separation is 
performed in order to separate isomeric compounds. The separation of isomers is desired for 
this study due to its clinical importance. 
Chromatographic conditions were optimized by testing two chromatographic columns (C18 




pH (ammonium acetate used as a buffer, pH adjusted by formic acid) and ion pairing reagents 
(heptafluorobutyric acid and hexanesulfonic acid). 
3.4.1.1 Acetonitrile as an organic solvent in the mobile phase 
 
The chromatographic analysis was first performed with an ACQUITY UPLC HSS C18 (1.8 
µm, 2.1 x 100 mm) column with water and acetonitrile as mobile phases, both containing 
0.1% formic acid. Chromatographic conditions of individual acylcarnitines were adjusted by 
testing gradient elution, column temperature, and flow rate of the mobile phase to achieve an 
optimal balance between the separation of acylcarnitines and time of the analyses.  
Individual acyl carnitine reference standards were diluted 250x in the sample dilution solvent 
(water:methanol 1:1) prior injection. A volume of 3 µl of the diluted sample was injected at a 
flow rate of 0.3 ml/min. In the beginning, gradient elution was as follows: 0-15 min linear 
gradient from 70% A, 30% B to 1% A, 99% B; 15-18 min 1% A, 99% B; 18-19 min 70% A, 
30% B. The temperature of the column was set to 50ºC to speed up the separation process. A 
good separation of the medium-chain and long-chain acylcarnitines (C8-C18) was achieved 
under the described conditions. Nevertheless, acylcarnitines with the chain-length C0 to C6 
eluted too early due to the strong mobile phase composition. Optimization of the 
chromatographic separation was performed by prolonging the time of the analysis and testing 
different gradients with the weaker initial mobile phase. Each measurement was performed 
3x. The following gradients were tested: 
•    0-3 min 90% A, 10 %B; 3-3,5 min 80% A, 20% B; 3,5-20 min linear gradient to 1% A, 
99% B; 20-23 min 1% A, 99% B; 23-24 min 90% A, 10% B.  
Better separation of the medium-chain acylcarnitines including separation of the C5 isomers 
was achieved.  
A weaker initial mobile phase was tested to prolong retention time of polar short-chain 
acylcarnitnes in the following gradient elution: 
•    0-3 min linear gradient from 99%A, 1% B to 95% A, 5 %B; 3-3,5 min 90% A, 10% B; 
3,5-20,5 min linear gradient to 1% A, 99% B; 20,5-23 min 1% A, 99% B; 23-24 min 99% A, 




The retention time of the short-chain acylcarnitines was prolonged when using only 1% of 
acetonitrile in the initial mobile phase, however, C0-C4 acylcarnitines co-elute and the polar 
glutarylcarnitine (C5DC) elutes in the dead volume. A sufficient separation of the medium 
and long-chain C6 to C18 acylcarnitines can be performed in shorter time (with steeper 
gradient) to speed up the analysis.  
•    0-3 min 95% A, 5 %B; 3-18 min linear gradient to 1% A, 99% B; 18-21 min 1% A, 99% 
B; 21-22 min 95% A, 5% B. 
 The problem regarding the low retention of polar compounds persists. However, a partial 
separation of two isomers with the acyl-chain length C4 and two isomers with the acyl-chain 
length C5 was achieved. Short-chain acylcarnitines C0, C2 and C3 co-elute in one peak. A 
sufficient chromatographic separation of the medium-chain and long-chain carnitines was 
achieved using a steeper gradient.  
Another way to improve the chromatographic separation is the optimization of the mobile 
phase’s flow rate. Flow rates of 0.1 ml/min; 0.2 ml/min, 0.3ml/min; 0.4 ml/min and 0.5 
ml/min were tested.  The flow rate of 0.2 ml/min provides the best result out of the five tested 
ones and therefore was applied during the first 3 minutes of the analysis when the short-chain 
polar acylcarnitines and two pairs of isomers co-elute. The flow rate of 0.3 ml/min was 
satisfactory for the separation of the medium-chain and longer acylcarnitines.  
Another separation problem occurred when trying to repeat the analysis. Repeated 
measurements provided chromatograms showing the long-chain hydrophobic acylcarnitines 
only. Polar short-chain C0 to C5 carnitines co-eluted (see figure 10). This separation problem 
occurred due to a short equilibration of the column. The time of the analysis was prolonged 
for 5 more minutes, which was necessary for the column equilibration with following 
conditions: 22-28 min 95% A, 5% B with the flow rate of 0.4 ml/min to speed up the process 





Figure 10  Achieved separation of acylcarnitines (A) and a separation problem in the repeated measurement (B). 
 
 
Figure 11 Separation problem was solved by longer equilibration of the column. Five minutes for the column 
equilibration was added after the gradient elution to avoid co-elution in the repeated measurements. Original 
gradient elution (left) and new gradient elution with added equilibration time (right)  
 
3.4.1.2 Methanol as an organic solvent in the mobile phase 
 
The optimization of the chromatographic conditions was tested by varying the organic solvent 
composition. Acetonitrile in the mobile phase was replaced by methanol. Both mobile phases, 
water (mobile phase A) and methanol (mobile phase B), contained 0.1% of formic acid. 
Methanol is a weaker mobile phase than acetonitrile, and thus, better separation and longer 
retention time of the short-chain acylcarnitines was expected. The gradient was adjusted for 
the weaker mobile phase composition. No significant chromatographic improvement was 
observed when using methanol instead of acetonitrile (figure 12). A signal of an unknown 





Figure 12 Separation achieved with acetonitrile (ACN, upper chromatogram) in the mobile phase was slightly 
better than with methanol (MeOH, bottom chromatogram).  
 
3.4.1.3 Ammonium acetate as a buffer 
 
Pieter Giesbertz et al. described a method for the analysis of acylcarnitines species including 
isomeric forms in plasma and liver tissues, where he achieved a chromatographic separation 
using C18 column, water and acetonitrile as a mobile phase, and ammonium acetate as a 
buffer [9]. The pH was adjusted with formic acid. Inspired by his method, ammonium acetate 
was added to both mobile phases, water/acetonitrile, and water/methanol, containing 0.1% 
formic acid. The concentration of the ammonium acetate used in this experiment was 10mM 
[6]. There was no significant separation improvement when adding ammonium acetate as a 





Figure 13 Comparison of the separation achieved with various mobile phases (ACN and MeOH, upper 
chromatograms) and separation achieved with and without adding ammonium acetate as a buffer (bottom 
chromatograms).  
 
3.4.1.4 Amide column 
 
Chromatographic separation was tested on an amide column X Bridge BEH Amide (2.5 µm, 
2.1 x 75 mm) column XP at column temperature 50°C. The purpose of using amide column 
was to achieve a better separation of isomers with acyl-chain length C4 and C5 by prolonging 
a retention time. The amide column is designed to retain analytes and metabolites that are too 
polar to retain by reversed-phase chromatography. The stationary phase was developed for 
hydrophilic interaction chromatography to separate extremely polar analytes [40]. Therefore, 
gradient elution was performed also with a strong initial mobile phase (unlike when using 
C18 column). Non-polar long-chain acylcarnitines were expected to elute first, followed by 
the medium-chain acylcarnitines. Polar short-chain acylcarnitines and C4 and C5 isomers 
were expected to retain in the column and elute with the weaker mobile phase at the end of 
the gradient elution.  
Variables tested when using amide column include solvent composition, the gradient elution, 
the flow rate of the mobile phase and an effect of ammonium acetate buffer added to the 
mobile phase.  
A mixture of four isomeric species of acylcarnitines was prepared.  Two C4 isomers 




isovalerylcarnitine) were diluted 50x in the dilution solvent (water:methanol 1:1). Each 
measurement was performed twice. The mobile phase consisted of 0.1% FA in water (mobile 
phase A) and 0.1% FA in acetonitrile (mobile phase B). The flow rate of the mobile phase 
during the experiment was 0.3 ml/min.  
Various gradient elution conditions were tested in order to obtain a desired separation. First, 
starting with a weak initial mobile phase (5% and 10% of ACN), the eluents were linearly 
increased up to 50%, 70%, 90% and 99% of ACN to investigate the optimal steepness of the 
gradient. Second, the gradient with a decreasing strength of the mobile phase was applied. 
Starting with a high percentage of ACN (50%, 70%, 90%, 99%) in the mobile phase, the 
eluents were linearly changed to 5% of ACN. The column was equilibrated for 5 min after 
each analysis. Isocratic elution with 50% ACN for 10 min was also performed but did not 
provide any good separation. 
The gradient elution that provided the best result out of the tested ones was as follows: 0-7 
min 90% A, 10% B to 70% A, 30% B; 7-10min 90%A, 10% B; 10-15min 90% A, 10% B. 
Using the described gradient elution, acylcarnitines with acyl-chains of the length C4 and C5 
were separated; however, their isomers co-eluted. The different gradient elution did not 
provide sufficient separation of C4 and C5 acylcarnitines. Adjustments of the 
chromatographic conditions were performed by varying the composition and the flow rate of 
the mobile phase. Optimal flow rate of 0.3 ml/min was chosen after testing flow rates of 0.2 
ml/min, 0.3 ml/min, 0.4 ml/min and 0.5 ml/min.  
Variations of the gradient elution described above were also performed with a mobile phase 
that consisted of 0,1% formic acid in water (mobile phase A) and 0,1% formic acid in 
methanol (mobile phase B) instead of the acetonitrile. Methanol in the mobile phase provided 
a slightly improved separation of C4 and C5 acylcarnitines when using the following gradient 
elution: 0-7 min 90% A, 10% B to 70% A, 30% B; 7-10min 90%A, 10% B; 10-15min 90% 
A, 10% B.  Isomeric forms were not sufficiently separated, though.  
Ammonium acetate was added to the tested mobile phases as a buffer. Ammonium acetate (10 
mM) in water (eluent A1) and ammonium acetate (10 mM) in acetonitrile (eluent B1), and 




methanol (eluent B2),  were used to create the gradient of the mobile phase (flow rate: 0.3 
ml/min). Addition of ammonium acetate as a buffer did not enhance the separation efficiency. 
To summarize the experiment, the amide column did not provide any better results than the 
C18 column regarding the chromatographic separation. The main goal of using amide column 
was to improve the separation of the isomeric acylcarnitine species. It was a step back instead 
since the biggest success included only the separation of C4 and C5 acylcarnitines which was 
achieved already before with the C18 column. Despite similar retention times of the isomeric 
pairs, their separation was still more significant when using C18 column, since the two pairs 
of the isomers co-elute on the amide column. The optimization of the method performed on 
the amide column by varying parameters such as a mobile phase composition, gradient 
elution, flow rate and adding ammonium acetate as a buffer did not lead to any improvement 
in the chromatographic separation. Therefore, the C18 column was chosen for further 
laboratory work in method development of the acylcarnitine profile analysis. 
 
3.4.1.5 Ion-pairing reagents (IPR) 
 
To prolong the retention time of the short-chain acylcarnitines, ion pairing reagents (IPR), 
such as heptafluorobutyric acid (HFBA) and hexanesulfonic acid (HSA), have been used as 
additives. The purpose of applying an ion pair reagent is to prolong the retention time of ionic 
analytes on hydrophobic columns.  Ion pairing reagent is an ion species with an opposite 
charge to the analyte of interest, so an ionic interaction can connect the two molecules in 
order to form a molecular association [41, 42]. The ionic interaction is subsequently destroyed 
in the ionization source of MS instrumentation which results in detection of the analyte of the 
interest (not the molecular association). IPR normally improves separation of polar 
compounds. Compounds used as IPR are strong organic acids when analyzing amines 
(acylcarnitines). These organic acids contain hydrophobic alkyl chain which allows binding to 
the stationary phase in the C18 column. Peng et al. described a successful separation of the 
acylcarnitines using heptafluorobutyric acid as an IPR [38]. However, IPR is not compatible 
with MS detection. When using a traditional detector, the mobile phase containing an IPR 
passes through the detector and goes to waste or can be collected for further studies. There are 




detector. The reason why IPR is not compatible with MS detector is that the eluate from the 
chromatographic column is deposited in the ion source, and thus non-volatile additives cannot 
be used. In the traditional procedure, IPR added to the mobile phase is continuously 
introduced into the mass spectrometer, which can cause its contamination that leads to signal 
reduction, ion suppression and requires laborious cleaning procedures afterward [42]. 
Bergman et al. developed an LC/MS ion-pairing chromatography for the analysis of 
catecholamines [42]. This new approach to ion-pairing chromatography was applied to our 
samples of acylcarnitines that were posing significant challenges to LC-MS/MS method 
development. In this method, IPR is added directly to the sample vials instead of adding it to 
the mobile phase. Thus, the amount of IPR introduced to LC-MS/MS is significantly lower; 
therefore the negative impact on the MS detector is reduced to the minimum.  
 
Figure 14 Ion-pairing reagents tested in this study were heptafluorobutyric acid and 1-hexanesulfonic acid sodium 
salt  
Two ion-pairing reagents were chosen for further investigation: heptafluorobutyric acid 
(HFBA) [41] and 1-hexanesulfonic acid (HSA) [42]. Investigation of the new method with 
the introduction of IPR into the sample included varying IPR concentrations and gradient 
elution. A mixture of the short-chain acylcarnitines (of acyl-chain lengths C0, C2, C3, two C4 
isomers, two C5 isomers, and C5DC) was diluted 50x in the dilution solvent (methanol:water 
1:1). The aim of the experiment with IPR added to our samples was to prolong their retention 
and enhance the separation of both, the polar compounds and the isomeric species. A mixture 
of all the acylcarnitines of the acyl-chain lenghts C0-C18 (with the same dilution) was also 





The mixture of C0-C5 was first analyzed without IPR and then with various concentrations of 
HFBA (6mM, 12mM, 30mM, 45mM). Gradient elution was as optimized as follows: 0-3 min 
95% A, 10% B; 3-6 min 40% A, 60%  B, 6-9 min 95% A, 5% B, 9-12 min 95%A, 5% B. A 
full scan analysis of the pure mixture displays all the present acylcarnitines and the persistent 
separation problem. Figure 15 shows the full scan chromatogram and dispays individual 
molecular ions of acylcarnitines present in the mixture.  
 
 
Figure 15 Mix of short-chain acylcarnitines C0 – C5 was separated with following gradient elution: 0-3 min 5% 
ACN,3-9 min 60% ACN, 9-12 min 5% ACN (bottom chromatogram). The mass of each acyl carnitine in the 





 After adding HFBA to the sample, the results did not show any peaks in the chromatogram 
that could indicate the presence of acylcarnitines (figure 16 and 17). Acylcarnitine and IPR 
form an ionic interaction which should be broken in the ionic source of MS instrumentation. 
The same m/z values of acylcarnitines were therefore expected in the chromatogram. 
Apparently, HFBA is too strong organic acid that can cause unwanted side reactions or a 
strong ion suppression of the acylcarnitine molecules [9]. Two dominant peaks of m/z 171 
and 225 are present in all the samples that contain HFBA, but none of them is an 
acylcarnitine. The gradient elution was adjusted by prolonging the time of equilibration: 0-3 
min 95% A, 10% B; 3-6 min 40% A, 60%  B, 6-9 min 95% A, 5% B, 9-15 min 95%A, 5% B 
 
Figure 16 Short-chain acylcarnitines (C0-C5) were not displayed in the chromatograms after adding an increasing 





Figure 17 Separation of all the acylcarnitines without adding HFBA (bottom chromatogram) and after adding 
HFBA (upper chromatogram). 
 
Parent ion scan was applied to the same set of samples. In this mode, a product ion of m/z 85 
was selected, and the scan shows all the parent ions which have fragmented to give that a 
product ion with m/z = 85. All the acylcarnitines contain the product ion of m/z 85, and thus 
the purpose of using the parent ion scan was to investigate if the carnitines are present in the 
samples with HFBA. Scanning parent ions of m/z 85 in the pure mixture (without added IPR) 
clearly show the presence of C0 – C5 acylcarnitines (figure 18). Presence of HFBA in any of 
the tested concentration caused a significant fragmentation and confirmed our hypothesis that 
HFBA, as a strong organic acid, may cause unwanted side reactions, a breakdown of the 





Figure 18 Parent ion scan applied for the analysis of short-chain acylcarnitines (C0-C5) without adding HFBA 
(bottom chromatogram) and after adding an increasing amount of HFBA (upper chromatograms) 
 
 To conclude the experiment, HFBA is not a suitable ion pairing reagent for the analysis of 
acylcarnitines.  
Hexanesulfonic acid 
Sulfonic acids were introduced as possible IPR candidates by Bergmann et al. in her article 
about the analysis of catecholamines [42]. A pure mixture of C0-C5 (without added IPR) was 
analyzed first, and then an analysis of a mixture containing various concentrations of HSA 
(6mM, 12mM, 30mM, 45mM) was performed. Gradient elution was optimized as follows: 0-
3 min 95% A, 10% B; 3-6 min 40% A, 60%  B, 6-9 min 95% A, 5% B, 9-12 min 95%A, 5% 
B. Various concentrations of HSA in the sample caused the same effect as HFBA; the results 




acylcarnitines. Two unknown peaks of m/z 171 and 225 (t~6.9 and t~8.1 respectively) that are 
not acylcarnitines, remain after adding HSA in any concentration (see figure 19).  
 
Figure 19 Separation of short-chain acylcarnitines (C0-C5) without adding HSA (upper chromatogram) and after 
adding HSA (bottom chromatogram) 
 
All the acylcarnitines are readily detectable in the pure mixture without any additives. 
However, full scan analysis and parent ion scan of samples containing HSA as the additive 
did not show any peaks in the chromatogram indicating a presence of acylcarnitines. A highly 
sensitive MRM method was therefore applied. The gradient elution was as follows: 0-3 min 
95% A, 10% B; 3-6 min 40% A, 60%  B, 6-9 min 95% A, 5% B, 9-12 min 95%A, 5% B. 
Following MRM transitions were applied: 
161  85 for L-carnitine (C0) 




218  85 for propionylcarnitine (C3) 
232  85 for butyrylcarnitine and isobutyryl carnitne (C4) 
246  85 for 2-methylbutyrylcarnitine and isovalerylcarnitine (C5) 
276  85 for glutarylcarnitine (C5DC). 
Acylcarnitines were detected in the sample with 45 mM HSA, and the retention time of the 
polar molecules was prolonged as expected. Nevertheless, the signal is nearly 3x weaker 
(figure 20). Acylcarnitines were detected by MRM method due to its specificity and 
elimination of the noise. The reduced detector response can be a manifested effect of 
competition for ionization efficiency in the ionization source between the short-chain 
acylcarnitines and HSA. Despite the prolonged retention time, the improvement of the 
chromatographic separation of the isomeric species was not achieved.  
 
 
Figure 20 Separation of short-chain acylcarnitines (C0-C5) without adding HSA (bottom chromatogram) and after 





To summarize this experiment, ion-pairing reagents are generally successful tools in ion-
paring chromatography. In traditional procedures, IPR is added in the mobile phase to make 
the polar molecules retain in hydrophobic columns. Since IPR in the mobile phase is not 
compatible with MS/MS detector, a new method that meets LC-MS requirements was 
developed, where the IPR is added directly to the sample [42]. This method was applied to the 
analysis of the acylcarnitines in order to improve the separation of polar acylcarnitines and 
isomeric species. Two IPRs were tested: HFBA and HSA respectively. No matter which IPR 
was used, a similar tendency was observed. HFBA caused a strong ion suppression and had a 
negative effect on the separation of acylcarnitines. HSA as an IPR made the polar molecules 
retain in the column longer. Nevertheless, the ion suppression occurred as well when adding 
HSA to the sample. For the mentioned reasons, IPR is not used for further laboratory work. 
3.4.1.6 Water as a dilution solvent 
 
Several testing runs were performed in order to investigate the effect of the dilution solvent 
on the sample appearance of the UHPLC-chromatograms. Water as a dilution solvent 
provides improved separation results for the polar acylcarnitines. Separation of the short-
chain polar acylcarnitines of the chain lengths C0, C2, C3 and C5DC was observed when 





Figur 21 Separation of the short-chain acylcarnitines was achieved when using water a dilution solvent.  
 
Due to the big challenge to separate polar short-chain acylcarnitines C0, C2, C3 and C5DC, 
further method development is focused on the acylcarnitines C4 to C18 that retain in the 
column. The separation of the short-chain acylcarnitines is a subject of another research.  
 
3.4.2 MS/MS method development 
 
Tandem mass spectrometry is a technique of interest in metabolomics due to the strong 
specificity and high sensitivity, not only in the determination of acylcarnitines. In this study, 
the technique involves mass selection of the target acyl carnitine ion, fragmentation of the 
mass-selected ion, and m/z analysis of the fragment ions with m/z 85 which is common to all 




selectivity through collision-induced dissociation in the collision cell. The first step in the 
method development is an investigation of the MS response and a development of SIM and 
MRM method. For the investigation of the MS response, it was necessary to determine if 
acylcarnitines can be ionized and if they can be detected without any chemical modification. 
This includes finding the optimal condition in the ion source and in the CE-collision cell. 
Both SIM and MRM methods were developed. In the SIM method, the abundances of ions of 
one or more specific m/z values are recorded. This mode of operation typically results in an 
increased sensitivity compared to the full scan mode (where the entire mass spectrum is 
recorded). All ions having target m/z value reach the detector (unlike in full scan mode). 
Higher selectivity is achieved with MRM method which uses two analyzers in SIM mode to 
select a quantifier and a qualifier ion of interest.  
The process of development of the MS/MS method involves a series of testing various 
parameters to achieve the optimal set of conditions. Parameters which need to be optimized 
for an MS detection and quantification of acyl carnitine molecules include MRM transition 
ions, capillary voltage, cone voltage, ionization mode, source temperature, dwell time and 
collision energy. 
 The mode chosen for ionization for detection was an electrospray operating in a positive 
mode. Dwell time corresponds to sampling rate of the detector. It is calculated from the peak-
width at the base. Reproducibility and accuracy is achieved with 10-15 data points across the 
chromatography peak [43]. Dwell time of 0.600 s calculated for the MRM in this study 







Figure 22 A workflow of MS/MS method development [14] 
 
3.4.2.1 Cone voltage 
 
Cone voltage was adjusted for both methods, SIM and MRM. Optimal cone voltage for the 
SIM method causes fragmentation of the molecular ion and provides both, molecular ion and 
fragment ions. Ideally, the settings of the ion source should provide high abundance of the 
molecular ion and high abundance of one or two fragment ions. The molecular ion can be 
used as the quantifier ion and the fragment ions as qualifier ions in quantitative analysis. 
Optimal cone voltage was determined for each acyl carnitine ester. The mixture of the 
acylcarnitines was diluted 50x in the dilution solvent (methanol:water 1:1) and analyzed in 
full scan mode with various CV (15V, 20V, 25V, 30V, 35V, 40V, 45V, 50V, 55V). Each 
measurement was performed twice. The spectrum of each acyl carnitine was evaluated, and 
the optimal CV that provided required fragmentation was chosen. 
SIM-based analysis were subsequently performed with the optimal CV, and the limit of 
detection (LOD) and the lower limit of quantification (LLOQ) were determined for individual 
acylcarnitines. The detection limit is the lowest quantity of the acyl carnitine that can be 
distinguished from the noise [44]. Visual determination of the LOD was performed by 
preparing samples with known concentrations of acylcarnitines and by establishing the level 
of reliable detection. Signal to noise ratio (S/N) 3:1 is considered acceptable to estimate LOD 
and was determined by visual evaluation of spectra. S/N 10:1 is considered acceptable to 




individual acylcarnitines [45]. The LOD determined by the SIM method was in the range of 
hundreds pg/ml. The LLOQ was calculated as a triple fold of the LOD.  
The cone voltage was adjusted for the MRM method. The optimal cone voltage for the MRM 
method is usually lower than the one for the SIM method in order to obtain a higher yield of 
the molecular (mother) ion (figure 23). The mother ion selected in the first quadrupole is sent 
to the collision cell (second quadrupole) where the collision-induced dissociation takes place. 
A fragment of interest (daughter or product ion) is selected in the third quadrupole. The high 
specificity is achieved by double selective monitoring of the molecular ion and its product 
ion. The optimal cone voltage was determined for each acyl carnitine. The area of each 
chromatography peak of acylcarnitines was calculated by the software. The cone voltage of 
choice provided a molecular ion with the largest area.  
 
 
Figur 23 Optimization of CV for MRM (left) and SIM method (right) 
 
3.4.2.2 Collision energy 
 
Collision-induced dissociation is a technique to induce fragmentation of selected ions in the 
collision cell to obtain their product ions. Molecular ions selected in the first quadrupole are 
fragmented in the gas phase by collisions with molecules of an inert gas. Product ions are 
subsequently selected in the third quadrupole before reaching the detector.  The efficiency of 
formation of product ions in MS/MS depends on the collision energy, nature of the collision 
gas, and flow rate of the collision gas. Argon was used as the collision gas. Product ion scan 
operational mode was chosen for an investigation of the optimal flow rate of the collision gas 




an important parameter to obtain a good fragmentation. The initial flow rate of 0.3 ml/min 
was too strong and led to inadequate fragments only. A flow rate of 0.2 ml/min was not 
enough due to the opposite reasons. Enough fragmentation was achieved with the flow rate of 
the collision gas of 0.25 ml/min.  The molecular ion of each acyl carnitine was selected and 
various CE values tested. Product ion scan gave all the product ions resulting from the 
fragmentation of the molecular ion. CE was optimized for each acyl carnitine. The 
fragmentation of all the acyl carnitine molecules led to a common product ion m/z 85. All the 
MRM transitions of acylcarnitines contained the common specific product ion of m/z 85. The 
measured m/z value of the product ion was 84.89 due to an imperfect calibration of the 
UPLC-MS/MS instrument. 
LOD and LLOQ were determined using the MRM method. Samples diluted to the 
concentration in the range of tens pg/ml showed acceptable S/N ratio 3:1. LOD estimated 
with MRM method is lower than the LOD determined with SIM method due to the reduced 
noise. The LLOQ was calculated as a triple fold of the LOD.  
 
 
Figur 24 Example of the visual evaluation of the limit of detection of decanoylcarnitine with the acceptable signal-






3.5 Relative quantification 
 
The quantitative analysis starts with creating a standard curve. Linear dynamic range 
determines LLOQ and ULOQ. Oleoyl-1-
13
C-L-carnitine hydrochloride was applied as an 
isotope-labeled internal standard (IST). Isotope-labeled IST is used for quantification of 
endogenous compounds such as acylcarnitines [31]. The acylcarnitine of interest is measured 
relative to the added IST. The choice of IST is based on several requirements such as the 
same chemical properties as the analyte and possibility to separate IST from the analyte.  
Five samples for creating the standard curve were prepared by adding an increasing amount of 
the acyl carnitine mixture and equal amounts of 
13
C-isotope-labeled IST. The calibration 
samples contained acyl carnitine mix of concentrations 20ng/ml, 40 ng/ml, 80 ng/ml, 160 
ng/ml and 320 ng/ml. IST was added to each sample in concentration of 80 ng/ml.  
When applying 
13
C-isotope-labeled IST, correct mass spectral data from stable isotope 
labeling experiments for the distorting effect of naturally occurring stable isotopes must be 
calculated, because 1,1% of 
13
C isotope occurs naturally in all molecules [46]. 
The corrected area of 
13
C-labeled IST is used to create the standard curve, where y-axis 
displays a ratio of <area of analyte/area of 
13
C-labeled IST> and x-axis displays the amount of 
added analyte.  
In relative quantification, changes in a given sample are analyzed relative to another reference 
sample. Relative quantification was planned to be performed to analyze alterations in the 
acylcarnitine profile of patients with IBD against healthy control. However, technical failure 
of the UPLC-MS/MS instrument made it impossible to finish the measurement of calibration 
samples. The UPLC-MS/MS instrument is currently being replaced and the measurement of 










4 Method Validation 
Method validation is performed to demonstrate the reliability of the method and to determine 
concentration of the molecule of interest in a biological matrix such as plasma, serum, blood, 
urine, tissue, food or environmental samples. This method was developed to determine the 
acyl carnitine profile in the colon biopsy. Validation is required whenever a new method is 
established [47]. The validation parameters of a bioanalytical method are given to ensure the 
reliability of the final results. Some of the relevant parameters recommended by the 
regulatory bodies include selectivity, specificity, accuracy, precision, the limit of detection, 
lower limit of quantification, carry over, calibration curve, matrix effects, robustness and 
ruggedness [48].  
4.1 Selectivity and specificity 
 
Selectivity refers to the extent to which a method can differentiate the analytes of interest and 
internal standards from components in the matrix or other components present in a sample. A 
selective method should be able to determine an analyte of the interest without interferences 
from other molecules present in a sample [48]. Specificity means 100% selectivity when 
interferences are supposed to occur. One of the approaches to assess selectivity is an analysis 
of certified reference materials [45]. Specificity (100% selectivity) was achieved with the 
development of the UHPLC separation method and the specific MRM method. UHPLC 
coupled with MS/MS detection method involves 3 selective steps; the first selection takes 
place in the chromatography column, the second and the third selection steps are performed 
by two mass analyzers in the MS instrumentation. MRM operational mode selects a 
molecular ion of interest and subsequently a fragment ion of interest which comes from 
fragmentation of the selected molecular ion. Probability that one compound provide exactly 




Accuracy indicates a degree of agreement how close is the experimental value to the true 




systematic errors affect a method. In bioanalytical methods, accuracy is expected to be better 
than 15% [47]. Systematic errors include personal errors, errors of the method or errors of the 
instrument [45]. In theory, they can be minimized during the method development. Two 
major strategies used to determine accuracy involve measuring an analyte of interest in a 
reference material and comparing the result with a certified value or determination of the 
concentration of an analyte in the sample by means of the standard addition technique [45]. 
Standard addition technique is used when blank samples are not available, such as analysis of 
endogenous compounds in human samples (acyl carnitine profile alteration in colon biopsies). 
Due to the instrument failure, experiment to determine accuracy could not be performed.  
4.3 Precision 
 
Precision describes how close the repeated individual measurements under specific conditions 
are. Precision leads to the repeatability and reproducibility in the method validation. A 
difference between repeatability and reproducibility was explained by P.Araujo in his paper 
[45]: “The repeatability ensures that the variability of the results remains constant under 
identical conditions... The reproducibility makes certain that the variability of the results 
remains under different conditions and the variation of one or more factors does not 
contribute significantly to the variability of the results”.   Random errors that affect precision 
can be caused by different uncontrollable variables [45]. The precision is determined by 
replicating the measurement. 
 





4.4 Limit of detection 
 
The limit of detection is defined as the lowest amount of the analyte of interest which is 
possible to detect with certain reliability. Different approaches are used to determine the 
LOD, such as visual determination or calculation of the signal to noise relationship. It is 
mainly based on a minimum signal-to-noise ratio related to a noise baseline. For 
chromatographic separation techniques, S/N ratio shall be minimum 3:1 [44, 45]. An 
approach for determination of the LOD used in this study was based on a visual determination 
of the LOD, performed by preparing samples with the known concentration of the analyte 
[44].  
4.5 Lower limit of quantification 
 
The lower limit of quantification defines the lowest concertation of the analyte that can be 
quantified and determined with a certain level of precision and accuracy. The LLOQ is 
evaluated by using similar approaches as for LOD as described in the previous paragraph. 
LLOQ can be determined based on the visual evaluation of based on the S/N ratio. S/N ratio 
is normally defined 10:1 for estimating LLOQ [45, 47]. LLOQ is considered being the lowest 
calibration standard. LLOQ was calculated as the triple fold of the LOD.   
 
Figur 26 Schematic representation of LOQ and LOD. S/N of 10:1 determines LOQ (upper peak) and S/N of 3:1 




4.6 Calibration curve 
 
Five calibration standards were prepared to perform five-point calibration. For quantification 




C -oleoyl carnitine was 
added to the mixture of acylcarnitines. Calibration curves are generated by addition of the 
increasing amount of acyl carnitine standard mixture and the same amount of the isotope-
labeled IST. When using 
13
C labeled internal standards, a corrected value of the mass 
spectrometry data must be calculated due to a natural abundance of the heavy stable 
13
C 
isotope. The linear range of the calibration curve determines LLOQ and ULOQ [44]. 
Unfortunately, calibration standards could not be measured due to the failure of the 
instrument. Therefore, calibration curves are not included in this project. 
4.7 Carryover 
 
Carryover is caused by residual analyte from a sample from the previous run. This parameter 
should be investigated and minimized because it can affect accuracy and precision [49]. 
Carryover was assessed by injecting a blank sample after analyzing a high-concentration 
sample. Carryover in the blank sample was not greater than 20% of the LLOQ.  
4.8 Stability 
 
Acyl carnitine reference standards were stored in -20°C. Solutions of individual acylcarnitines 
and acyl carnitine mixtures were stored at 4°C. It was observed that the solutions were stable 
when stored at room temperature overnight prior analysis.  
4.9 Robustness 
 
Robustness is defined as the non-significant reaction of an analytical method to small changes 
of the internal parameters [45] such as flow rate, column temperature, injection volume, 
mobile phase composition or cone voltage. This analytical method was robust in terms of 
mobile phase composition, injection volume, column temperature, and cone voltage. Mobile 




acetonitrile/water. Various injection volumes and various column temperatures did not affect 
the analytical method. Significant variation in fragmentation was observed with variations of 
the flow rate of the collision gas. The optimal flow rate of the collision gas 0.25 ml/min 
provided sufficient fragmentation while the flow rate of 0.3 ml/min was already too strong 
and resulted in tiny fragments only. Collision energy must have been adjusted according to 
the flow rate of the collision gas. Thus, the robustness of the method was weak in terms of 
flow rate of the collision gas and collision energy.  
4.10 Ruggedness 
 
Ruggedness is defined as a non-significant reaction of an analytical method to external 
parameters. It evaluates how constant the results when varying factors such as analyst, 
instruments, laboratories or reagents. Ruggedness determines reproducibility under normal 
conditions [45]. The method development was performed in a laboratory at IFA using the 
same UHPLC-MS/MS instrument. I have performed all the measurements, therefore the 









5 Results  
5.1 Chromatographic separation 
 
Optimized UHPLC conditions are summarized in the table 5. 
Table 5 Optimized UHPLC conditions 
Column ACQUITY UPLC HSS C18 (1.8 µm, 2.1 x 100 mm) 
Mobile phase A: 0.1% FA in water 
B: 0.1% FA in acetonitrile 
Flow rate 0.2 ml/min (0-3 min) 
0.3 ml/min (3-22 min) 
0.4 ml/min (22-28 min) 
Gradient 0-3 min 95% A, 5% B 
3-18 min 1% A, 99% B 
18-21 min 1% A, 99% B 
21-22 min 95% A, 5% B 
22-28 min 95% A, 5% B 
Injection volume 300 µl 
Column temperature 50⁰ C 
Sample temperature Room temperature 





Chromatographic separation was obtained using an ACQUITY UPLC HSS C18 (1.8 µm, 2.1 
x 100 mm) column at the temperature of 50ºC on the column. A C18 column was selected 
over an amide column X Bridge BEH Amide (2.5 µm, 2.1 x 75 mm) column XP because of 
significantly better separation achieved on the C18 column. The separation was achieved with 
water and acetonitrile as mobile phases, both containing 0.1% FA, at the flow rate of 0.3 
ml/min. A flow rate of the mobile phase was adjusted to 0.2 ml/min during the first three 
minutes of the analysis in order to obtain better separation of the short-chain acylcarnitines 
and isomers. Column equilibration was performed with the flow rate of 0.4 ml/min to speed 
up the process of equilibration. Gradient elution was as follows: 0-3 min 95% A, 5% B (flow 
rate 0.2 ml/min); 3-18 min linear gradient to 1% A, 99% B; 18-21 min 1% A, 99% B; 21-22 
min 95% A, 5% B; 22-28 min equilibration of the column with 95% A, 5% B (flow rate 0.4 
ml/min).  
 





A mobile phase consisting of water/acetonitrile with 0.1% FA was favoured over 
water/methanol with 0.1% FA due to the better ionization ability and the peak shape. 
Ammonium acetate as a buffer did not result in any significant changes regarding the 
chromatographic separation.  
Ion-pairing reagents were tested as additives in order to change retention time of the polar 
short-chain acylcarnitines on the hydrophobic C18 column. A new approach of ion pairing 
chromatography has been used to overcome the incompatibility of IPR with MS detection. 
IPR was added directly to the sample instead of the mobile phase to avoid the continuous 
flow of non-volatile IPR into the mass spectrometer [42]. Compounds used as IPR when 
analyzing acylcarnitines were strong organic acids such as heprafluorobutyric acid (HFBA) 
and hexanesulfonic acid (HSA). Adding IPR to the samples caused a strong ion suppression. 
Consequently, IPR was not used further in this study.    
The continuous problem with the co-elution and the short retention of the short-chain 
acylcarnitines was partially solved after exchanging the dilution solvent. Separation of the 
short-chain polar acylcarnitines of the chain lengths C0, C2, C3 and C5DC was observed 
when using water as a dilution solvent (instead of water:methanol 1:1). Better separation of 
short-chain acylcarnitines could have resulted from weaker eluotropic strenght of the dilution 
solvent. Differences in the solvent strengh might have caused changes in retention behaviour 





Figur 28 Separation of polar acylcarnitines when using water as a sample diluent 
 
5.2 MS/MS parameters 
 
The process of development of an MS/MS method involves testing a series of various 
parameters which include ionization mode, MRM transition ions, capillary voltage, cone 
voltage, source temperature, dwell time, and collision energy. Acylcarnitines were ionized 
using ESI in positive mode. Optimized MRM conditions are summarized in the table 6.  
Table 6 Optimized MRM conditions 
Ionization mode ESI+ 
Capillary 3.0 kV 
Source temperature 200⁰ C 
Collision gas Argon 
Collision gas flow rate 0.25 ml/min 





Cone voltage was adjusted for both, SIM and MRM method. Optimal cone voltage for the 
SIM method causes fragmentation of the molecular ion and provides both, molecular ion and 
fragment ions. An increased selectivity was achieved by monitoring the molecular ion and the 
fragment ion as a quantifier and qualifier ion respectively. The CV was optimized for each 
acyl carnitine. Subsequently, LOD and LLOQ were determined in the SIM mode. S/N 3:1 
was observed with the final dilution 1 000 000x and 5 000 000x which corresponds to the 
concentration of 1 ng/ml and 200 pg/ml respectively. Optimal CV for the SIM method, LOD 
and LLOQ are shown in the table 7. 
 
Table 7 Optimal CV for SIM, LOD and LLOQ determined by SIM 
Acylcarnitine Acyl [M+H]
+
 CV [V] LOD [ng/ml] LLOQ [ng/ml] 
Butyrylcarnitine C4 232 40 0,2 0,7 
Isobutyrylcarnitine C4 232 40 0,2 0,7 
2-methyl-butyrylcarnitine C5 246 40 1 3 
Isovalerylcarnitine C5 246 40 0,2 0,7 
Hexanoylcarnitine C6 260 40 0,2 0,7 
Octanoylcarnitine C8 288 45 0,2 0,7 
Decanoylcarnitine C10 316 45 0,2 0,7 
Lauroylcarnitine C12 344 50 1 3 
Myristoylcarnitine C14 372 50 1 3 
Palmitoylcarnitine C16 400 50 0,2 0,7 
Stearoylcarnitine C18 428 55 0,2 0,7 





The optimal cone voltage for the MRM method was lower than the CV for the SIM method in 
order to achieve a very gentle fragmentation that yields to the large amount of the molecular 
ion. The optimal cone voltage was determined for each individual acyl carnitine. Cone 
voltage of choice for MRM provided the highest yield of molecular ions. 
Molecular ion of each acyl carnitine was selected in the first quadrupole and sent to the 
collision cell (second quadrupole), where the collision-induced dissociation produced 
fragment ions. Product ion of interest (m/z 85 for all the acylcarnitines) was selected in the 
third quadrupole. Parameters such as collision energy and flow rate of the collision gas were 
optimized in order to achieve an optimal production of ions of m/z 85. Optimal parameters 
were obtained with the daughter ion scan method. The flow rate of the collision gas (argon) 
was optimized to 0.25 ml/min. The collision energy of individual acylcarnitines was adjusted 
accordingly to provide sufficient fragmentation.  
LOD and LLOQ were determined with the MRM method. LOD was determined by visual 
evaluation of chromatograms. Estimated LOD with S/N ratio 3:1 corresponds to 
concentration 10 pg/ml. LLOQ was calculated as a triple fold of the LOD. The LOD and 
LLOQ determined with MRM method were lower than with SIM due to eliminated noise. 





Table 8 MRM transitions, optimized CV and CE, LOD and LLOQ determined by MRM 








Butyrylcarnitine C4 232 85  30 25 10 30 
Isobutyrylcarnitine C4 23285  30 26 10 30 
2-methyl-butyrylcarnitine C5 24685  30 26 10 30 
Isovalerylcarnitine C5 24685  30 26 10 30 
Hexanoylcarnitine C6 26085  30 26 10 30 
Octanoylcarnitine C8 28885  33 26 10 30 
Decanoylcarnitine C10 31685  37 26 10 30 
Lauroylcarnitine C12 34485  38 26 10 30 
Myristoylcarnitine C14 37285  38 26 10 30 
Palmitoylcarnitine C16 40085  38 28 10 30 
Stearoylcarnitine C18 42885  38 30 10 30 












6.1 Metabolomic studies of carnitine for IBD research 
 
Metabolomics has recently gained considerable interest because it enables system-wide 
measurements of metabolites and low-weight molecules in biological samples. Current 
metabolomic technologies are powerful tools in clinical medicine. Metabolomic studies stand 
behind the discovery of new therapeutic targets and biomarkers and thus has a big potential to 
add new knowledge to a field of clinical chemistry [30]. Carnitine gained an interest in the 
field of metabolomics due to its essential role in the energy metabolism and fatty acid 
transportation. Carnitine is a biomolecule that works as a carrier of activated fatty acids to the 
matrix via a mitochondrial membrane, where they undergo beta-oxidation [2]. Alterations in 
the acyl carnitine profile can provide clinically valuable information about metabolic 
disorders. Carnitine deficiency was associated with various diseases such as cirrhosis and 
liver disorders, obesity, endocrine disorders, diabetes and recently also with inflammatory 
bowel diseases (IBD) [4, 7].  
IBD is an inflammatory response to intestinal microbiota which is caused by a combination of 
genetic and non-genetic factors [11]. However, the pathogenesis of IBD remains unknown. 
Absorption of carnitines from the diet takes place in an intestine by an active and passive 
transport across membranes of enterocytes. Carnitine as a transporter of fatty acids to 
mitochondria plays a key role in the energy production for the intestinal tissues. Thus, 
acylcarnitines are investigated as potential biomarkers of IBD.  
Various acylcarnitines occur in isomeric forms or at very low concentrations. Development of 
a sensitive and selective method is necessary in order to analyze acyl carnitine profile 
including isomeric species because of their clinical relevance. The invention of hyphenated 
technique UHPLC-MS/MS was a big step forward in the clinical analysis. The development 
of the bioanalytical UHPLC-MS/MS method requires optimization of three main steps 
including a sample preparation, chromatographic parameters and the mass spectrometry [14]. 
All the three steps can influence each other and require adjustments of several parameters. 
Bioanalysis of acylcarnitines meets certain challenges. Previously mentioned low abundance 




technique. Acylcarnitines contain acyl-chains of various chain-lengths which brings certain 
challenges during the separation due to different physicochemical properties of individual 
acylcarnitines. Here we have described a sensitive and selective method for the analysis of 
acylcarnitines by UHPLC-MS/MS.  
6.2 Chromatographic separation 
 
Modern UHPLC instrumentation has the potential to deliver the desired separation and 
narrow chromatography peaks. Despite of the modern instrumentation abilities, broader peaks 
and insufficient separation can appear. Several parameters must be considered before the 
analysis in order to obtain narrow peaks. Band broadening can be caused by too large 
injection volume or it can appear due to a wrong choice of the sample solvent [21]. It can 
occur in the chromatography column or in the tubing connecting an injector and the column 
or column and a detector. A good choice of the chromatographic and optimization of the 
chromatographic parameters such as the flow rate of the mobile phase and injection volume 
are essential in order to achieve desired resolution. 
The chromatographic separation was established using ACQUITY UPLC HSS C18 (1.8 µm, 
2.1 x 100 mm) column. Separation was achieved with gradient elution. The first problem 
occurred regarding the repeatability of the measurements. Repeated measurements provided 
weaker signals of the acylcarnitines and showed co-elution of the short- and medium-chain 
esters. One hypothesis to explain this problem was sample adsorption to the container. 
Quaternary ammonium cations and amines has a potential to adsorb to glass vials. Since the 
separation was very poor also with a freshly prepared mixture, the core of the problem was in 
an insufficient column equilibration. Longer equilibration of the column was essential to 
obtain the same chromatograms with repeated measurements. Total running time 28 min 
included 5 min of equilibration.  
 The separation problem regarding short retention and co-elution of the short-chain 
acylcarnitines remained due to their polar properties. Gradient elution with very weak mobile 
phase consisting of acetonitrile/water prolonged the retention time, however, acylcarnitines 
with short acyl chains such as C0, C2, C3 and C5DC co-eluted and isomeric species (two C5 




the polar carnitine species, amide column X Bridge BEH Amide (2.5 µm, 2.1 x 75 mm), 
column XP was applied. A hydrophilic stationary phase of the amide column was designed to 
retain polar analytes therefore the column was tested in order to solve the separation problem 
and improve the poor resolution. Optimization of the method performed on the amide column 
did not lead to any improvement of the chromatographic separation. Therefore, C18 column 
was chosen for the further laboratory work. 
Solvent composition was one of the variables tested in order to achieve sufficient separation. 
Acetonitrile/water and methanol/water, both mobile phases containing 0.1% FA were applied. 
FA is added to provide a source of protons. Acetonitrile and methanol are organic solvents 
commonly used as mobile phases in reversed-phase chromatography. Acetonitrile is 3x more 
expensive than methanol, however, analytical conditions point at acetonitrile as a solvent of 
choice for several reasons. Given the same flow rate, acetonitrile-based solutions apply less 
pressure on the column while the pressure for methanol increases when mixed with water. 
Elution strength of acetonitrile is generally higher, thus can be used in lower mixture ratio. 
Elution selectivity differs on each due to different chemical properties of protic (MeOH) and 
aprotic (ACN) solvents [15]. Since acetonitrile did not provide desired separation, methanol 
was tested. Chromatographic separation was comparable using the two mentioned solvents as 
a mobile phase. Selectivity and peak shape were generally better when using acetonitrile, 
therefore it was used despite its higher costs.  
Although analysis of acylcarnitine esters often includes derivatization to enhance sensitivity, 
analysis of underivatized acylcarnitines was previously described and performed in this study. 
Derivatization methods include synthesized reagents which can cause unwanted reactions that 
can influence determination of accuracy [2]. Thus, a UPLC-MS/MS method has been 
established to separate and identify underivatized acylcarnitines. To improve chromatographic 
separation, ion pairing reagents were involved. Traditional techniques involve adding an ion 
pair reagent to the mobile phase to prolong the retention time of ionic analytes on 
hydrophobic columns. However, IPR is not compatible with MS/MS detection. When using 
traditional detector, the mobile phase pass through the detector and goes to waste or can be 
collected for further studies. There are many restrictions with respect to the composition of 
the mobile phase when using a MS detector, because the eluate from the chromatographic 




introduced into the mass spectrometer which can cause its contamination that leads to signal 
reduction, ion suppression and requires long cleaning procedures afterward [42]. A new 
approach to ion-pairing chromatography was applied to our samples of acylcarnitines that 
were posing significant challenges to LC-MS/MS method development [42]. IPR was added 
directly to the samples instead of adding it to the mobile phase. Continuous introduction of 
IPR in the mobile phase was avoided and the negative impact on MS/MS minimized. 
Compounds used as IPR were strong organic acids HFBA and HSA for analysis of 
acylcarnitines. HSA was favored over HFBA as it made the polar molecules retain in the 
column longer, nevertheless, the signal was very weak probably due to a strong ion 
suppression. The chromatogram displayed unknown peaks that could have been caused by a 
contamination of the sample. Unknown peaks remained also when analyzing a new freshly 
prepared mixture, which means that IPR might caused unwanted reactions in the sample. For 
the mentioned reasons, IPR was not used for the further method development for analysis of 
acylcarnitines. Despite of testing various concentration of IPR, the lowest used concentration 
might have been still too high. Possibly, incubation was needed to obtain the molecular 
formation of acylcarnitines and IPR. Further investigation to determine the effect of lower 
concentrations of IPR added directly in the samples on ion suppression should be performed.  
Separation of the short-chain polar acylcarnitines of the chain lengths C0, C2 and C3 was 
observed when using water as a dilution solvent (instead of water:methanol 1:1). Water 
probably provided better environment for dissolution of the polar carnitines which enhanced 
their chromatography separation. Better separation of short-chain acylcarnitines could have 
resulted from weaker eluotropic strenght of the dilution solvent. Differences in the solvent 
strengh might improved retention behaviour of the polar compounds.  
 
6.3 Mass spectrometry 
 
ESI in positive mode was applied for ionization. Cone voltage was adjusted for two 
operational modes separately and for each individual acylcarnitine. Setting the cone voltage 
for individual carnitines is possible due to programmable time windows. The voltage settings 




different levels of fragmentation. Higher cone voltage was applied for SIM mode to obtain 
both, molecular and fragment ions. MRM method requires lower cone voltage to obtain high 
yield of a molecular ion which is fragmented later in a collision cell. Inicially, the collision 
energy was adjusted when using the flow rate of argon 0.3 ml/min.. The  flow rate turned to 
be too harsh since only tiny fragments were obtained undependently on the collision energy. 
Much lower rates resulted in insufficient fragmentation.  The adjustment of the argon flow 
rate turned out to be an influential parameter for the collision-induced dissociation. The flow 
rate of 0.25 ml/min provided the desired fragmentation. Collision energy was optimized using 
the flow rate of 0.25 ml/min. Collision induced dissociation produced the an intense 
characteristic daughter ion for acylcarnitines of m/z 85. The instrument provided m/z value of 
84,89 due to its imperfect calibration.  
Dwell time is another parameter which should be adjusted when using MRM method. MS is a 
digital technique which requires a complete control of the scan speed vs the peak width. The 
dwell time determines how often the chromatography peak should be sampled by the detector. 
It is calculated from the peak-width at the base. The optimal dwell time requires at least ten 
data points across the peak to describe the peak with some accuracy and reproducibility and to 
avoid introducing both systematic and random errors to the analysis. A dwell time that 
provides 10 -15 data points across the chromatography peak is optimal for accurate 
quantification, including low abundant analytes [43]. Dwell time of 0.600 s calculated for the 
MRM in this study corresponds to 15 data points.  
Limit of detection of individual carnitines was estimated by a visual evaluation using both, 
MRM method and SIM method. Visual evaluation method for determining LOD in the 
samples of known analyte concentration was favored over calculations based on the S/N ratio. 
Technical fails of the instrumentation software provided unreliable results of the S/N 
calculations.  The LOD was lower with MRM due the high selectivity of the method and 
consequent elimination of the noise.  
One of the methods for calibration is a stable isotope dilution. Stable isotope dilution is 
almost exclusively used with mass spectrometry due to its ability to distinguish isotopic 
species. Known amount of isotopically-labeled substance added to the sample changes the 
isotopic composition of the analyte. Isotope dilution employs signal ratios to determine the 




interest. Labelled and unlabelled compounds are presumed to behave identically due to the 
same physicochemical properties which means that IST follows the analyte through all the 
analytical steps in an identicall manner. The last detection step of the analytical assay allows 
their differentiation based on their different m/z values.  
Five calibration samples were prepared with increasing concentration of acylcarnitine mixture 
and constant amount of isotope-labelled internal standard oleoyl-1-
13
C-L-carnitine 
hydrochloride. However, a technical failure of the UPLC-MS/MS instrument made it 
impossible to finish the measurement of calibration samples. The UPLC-MS/MS instrument 
is currently being replaced and the measurement of the calibration samples is going to be 
performed on the new instrument. 
To evaluate UHPLC-MS/MS method performance, method was validated as described 







7 Concluding remarks  
The present project described the development of a novel method to separate and identify 
acylcarnitine esters with acyl-chain length C4-C18 including four structural isomers. Desired 
chromatographic separation was achieved on a C18 column using a mobile phase consisting 
of 0.1% formic acid in water and 0.1% formic acid in acetonitrile. This method does not 
require prior derivatization which speeds up the whole analysis and eliminates unwanted side 
reactions. Structural isomers with acyl-chain of C4 such as butyrylcarnitine and 
isobutyrylcarnitine and acyl-chain of C5 such as 2-methylbutyrylcarnitine and 
isovalerylcarnine were successfully separated.  This project involved a development of a high 
sensitivity MS/MS assay for the detection of acylcarnitines in the range of pg/ml. Highly-
specific MRM method was developed to determine individual acylcarnitine esters including 
isomeric species in the sample. The ability to separate and identify isomers is desired and 
clinically relevant for a biochemical screening of FAO and organic acid metabolism 
disorders. Acylcarnitine profile alterations have been associated with various diseases 
including IBD. Development of the new rapid and highly-sensitive method for analysis of 
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